Prof. Denise Fitzgerald, from Trinity’s School of Medicine, has been awarded €6.26 million Research Professorship funding ...

SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, ...

A new study identifies blood protein alterations, including DKKL1, that predict multiple sclerosis risk a decade before diagnosis.

Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve ...

A new study has revealed a group of blood proteins, that are altered in people who go on to develop multiple sclerosis (MS), ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy) data in adults with relapsing forms of multiple sclerosis (RMS) ...

A harmful protein called TDP-43 plays a major role in brain diseases like frontotemporal dementia and is also found in many ...

Summary: A collaborative neurobiology study uncovered a cellular mechanism tied to the severe, rapid progression of multiple sclerosis (MS). Published by a multidisciplinary team analyzing human ...

A noninvasive treatment called high-intensity focused ultrasound helped relieve the shaking, stiffness and pain that ...

Researcher Daan van der Vliet, together with colleagues from the Netherlands Institute for Neuroscience, Leiden University, and Utrecht University, has discovered an important mechanism that may be ...

Brain cells may get stuck in stress mode during multiple sclerosis, preventing myelin repair. A new drug fragment could ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that patient ...